Daunorubicin + Cytarabine + Venetoclax in de Novo AML
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
- Status
- RECRUITING
- Phase
- PHASE1
2321GCCC: CRD3874-SI in Patients With Relapsed/Refractory AML
- Status
- SUSPENDED
- Phase
- PHASE1
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Status
- RECRUITING
- Phase
- PHASE1
Twice-per-weekSelinexor, 2 Days Melphalan
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
VA as Maintenance Therapy Post Allo-HSCT in MDS and AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
- Status
- RECRUITING
- Phase
- PHASE1
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
- Status
- RECRUITING
- Phase
- PHASE4
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE1
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2